ICP
CVS icon

Interchange Capital Partners’s CVS Health CVS Stock Holding History

Interchange Capital Partners’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-6,234
Closed -$495K – 345
2025
Q4 		$495K Buy
6,234
+602
+11% +$47.5K 0.09% 201
2025
Q3 		$425K Buy
+5,632
New +$386K 0.08% 209
2024
Q4 		– Sell
-13,693
Closed -$861K – 270
2024
Q3 		$861K Sell
13,693
-959
-7% -$55.9K 0.3% 88
2024
Q2 		$865K Buy
+14,652
New +$917K 0.32% 84
2023
Q3 		– Sell
-3,194
Closed -$222K – 153
2023
Q2 		$222K Sell
3,194
-6,495
-67% -$462K 0.17% 137
2023
Q1 		$720K Buy
9,689
+7,469
+336% +$626K 0.39% 66
2022
Q4 		$207K Sell
2,220
-112
-5% -$10.8K 0.21% 121
2022
Q3 		$222K Sell
2,332
-226
-9% -$22.4K 0.24% 128
2022
Q2 		$237K Sell
2,558
-87
-3% -$8.49K 0.27% 121
2022
Q1 		$267K Sell
2,645
-237
-8% -$24.9K 0.27% 125
2021
Q4 		$297K Sell
2,882
-4,118
-59% -$381K 0.3% 112
2021
Q3 		$594K Buy
7,000
+300
+4% +$25.1K 0.99% 34
2021
Q2 		$559K Sell
6,700
-3,502
-34% -$287K 0.86% 37
2021
Q1 		$828K Sell
10,202
-532
-5% -$38.8K 0.45% 69
2020
Q4 		$733K Buy
+10,734
New +$698K 0.4% 65

Other funds holding CVS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Interchange Capital Partners's CVS Position: Q1 2026 in Review

Interchange Capital Partners sold out of CVS Health (CVS) in Q1 2026, closing a stake of 6,234 shares — an estimated $495K sold.

Interchange Capital Partners first reported a position in CVS in Q4 2020 and held it in 15 quarters. The position peaked at $865K in Q2 2024. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Interchange Capital Partners reported no remaining CVS Health position as of Q1 2026 after selling out during the quarter.
  • Interchange Capital Partners sold 6,234 CVS Health shares in Q1 2026, an estimated $495K.
  • Interchange Capital Partners first reported a position in CVS Health in Q4 2020 and held it in 15 quarters.
  • Interchange Capital Partners's CVS Health position peaked at $865K in Q2 2024.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Interchange Capital Partners's 13F filing for Q1 2026, filed 24 Apr 2026.